Louis Gries
Management
Okay, good morning, everybody. Same drill as always. I'll review the businesses pretty quick. I'll go through the slides fairly quick, give you an opportunity to drill down with your questions later and Russell will run through the financials. As you, I think, probably already saw, this isn't one of our best quarters. Not a terrible quarter, but not what we planned. So the net operating margin profit, excluding the normal stuff, is down and we'll go to the various reasons, there's no one reason for that, but there are various reasons that kind of led to that result. With the U.S. business, volume is up 6% which is a little short of what we have planned and we were thinking it would be more like 9%. And when you look at the full year, I think it's -- half year, sorry, or at half year, I think, it's like 11%. We'll get to that slide next. We did think the second quarter didn't have any problems in the volume side, it was just kind of a quarterly variance thing, because the order file right now is okay. First quarter was a little bit more than we thought, or right where we thought we could get, second quarter was soft. Price coming into the year, we gave you that guidance flat, plus or minus 2%, and we're down to minus 2% for both quarters, which is a little bit worse than we thought it would be, not a huge, obviously, reduction in price, but it is a stubborn reduction in average price. Now they have the same guidance the rest of the year, flat, plus or minus 2%. And we think we'll be looking more like the flat then right on the bottom of the range we gave you. It's still a little bit early to call out but it looks a little bit better. The EBIT, as I said, down 7%. Basically a few things we talked about. The volume wasn't quite where we thought we'd have it, the price a little bit below what we thought we have in the quarter. And then our costs -- on the cost side of the business, they were kind of where we thought we'd be in the quarter. So that basically delivered an 18.5% EBIT margin. We were thinking we're 3 points higher than that, so we did come in short of what we thought we would. When you look at the half year, I guess it's kind of the same story, just not as much quarterly variance. The sales volume is okay. We're indexing the market plus around 4.5%, 5%. So in old terms, where we just talked about PDG, that's kind of the range. The first half ran and now the second quarter is kind of a negative. In the first quarter, a positive to get to that 4.5%, and when I say a negative in the second quarter, it was just less than 1% negative. And as we've talked about that calculation, you never want to look at it quarter-to-quarter, it's just too much variance but through the first half of the year, about 4.5% or 5% right now. Average price, like I said, both quarters came in about the same, down 2% on last year. EBIT for the half year is flat even though we have the extra volume to work with, and that's again due to the price being off a bit and the cost up, which are more planned up than a problem being up and 19.2%. So right away, I mean, I'm sure we get every quarter with a 19.2% at half year, we don't expect to stretch up to the 20% for the full year. If we delivered that 3 points more in the second quarter, we would have a shot at it, but we don't really have a shot at it. It's not enough forecast anymore. It can be off a whole bunch but it's not going to stretch up to 20% for the full year. The net price, as I said, you can see we hit kind of our high price, in market price in fiscal year '11 and we're off a bit from that. Not really a price decline. There is some reduction in selling price into some segments, mainly multifamily and some of the Cemplank business. And there's also a bit of an increase in the mix on those products, and that's offsetting the mix improvement we have on some of our higher priced products. The price actually started coming off about this time last year, so that's why I think, for the rest of the year, we comp better than we did the first half of the year. Not that our prices are going to be necessarily higher but our comp will be lower, that we'll be going against. And then, I guess, this is a pretty telling chart, counted it up here, I can count to 10, and 7 out of the last 10 quarters, we're actually below our target, which I think for us and for people that invested in Hardie, that's a bit of a surprise. Now first half of that is more about just how low the market got when it is really kind of dead. So I think the first 4, 5 quarters of that is probably very good performance. I think what we've seen since, in the last 4, 5 quarters, we did really well moving from a boom market into a down market. We took a lot of cost out of the business, held our returns together. Our organization's actually struggling a little bit more than what I would've expected going back to market recovery, so trying to get back to growth. So obviously, we took cost out so we have to put cost back in, but the ramp up on that cost add isn't as efficient as I thought it would be. It was probably a bit naïve on my perspective but, at the end of the day, it's still the right thing to do to take the cost out because we had a long period of time we didn't have the cost in the business. The other thing is our business, our product mix especially, is quite different now than it was going into the downturn. So some of the costs we took out going into the downturn are actually costs we're not adding back in now. So we're adding back in a different kind of cost, both from a capacity standpoint or what we call MG&A and also from an SG&A standpoint. So like I said, I don't think -- so I think we're -- I'm not saying we couldn't hit a 20% in one of the 2 quarters remaining, but we've got 7 out of 10 below. Maybe we end up with 9 out of 12 below. And at that point, you guys say, "Well, that's where you guys live, right? 9 out of 10 below the target -- or 9 out of 12." I don't think that's the case. I just think, as we've indicated in the past, we would hate to pass up any kind of the growth opportunity window just to deliver inside that target range because it's a small difference based on what we are delivering. But if things kind of progress as they appear to be on the market side, we, as an organization, get our arms around building the organization back up, I would say we'd be aiming for that target again next year, and then expect, once we get into target, expect to live in the target for a long period of time, or above the target like we did in previous years. Of course, that all remains to be seen. The housing market itself, you guys would know all the facts. Most of us there in the industry believe it's recovering, and we're optimistic that it'll continue. So certainly, we're planning that the market will get better again next year. It's not going to shoot straight up. We don't expect it to spike. If it did, we'd have to scramble for capacity but that's not what we're expecting at all. So we're pretty well set up for kind of a bullish upside to what the forecasts are for next year. Asia Pac. Like the U.S., the only thing, a different story. Asia Pac did not run as well as we would expected it to last quarter, and really for the first half, I'd have to say the same thing. It's not that it ran poorly. It's having the opposite problem. It's just struggled a little bit more than we thought it was going to as the volume came off. Now a big part of that EBIT drop is a $5.7 million provision, we took in a New Zealand business, U.S. dollars. But even kind of moving that to the side, we were expecting the business to do a little bit better than it did in the second quarter. Again fundamentally, it's just a great business. There's nothing wrong with it. We're just in a short-term funk. We don't think it's a long-term trend at all, and we think we have good organization, a good strategy and we'll move forward in a more positive way, as even if this [indiscernible] strategy doesn't get much better, we think our results will start getting better. And half year again, it still is at $5.7 million in there, but the half year results minus the $5.7 million comes out to something like, I can't remember exactly, but it's like off 14 or 15 on the EBIT line. So like I said, it's not like we're expecting to grow EBIT or anything, but we think we could've done 4 or 5 points better than that. On the summary, I kind of gave it all to you. Of course, we have some more bullet points here. Again, housing market has gone from being a major concern to one that everyone's kind of feeling like we can operate in the current market, and certainly, we're one of those companies that feels that way. And we do feel it will continue to get better. We don't have any hard evidence but there's no real evidence that it's likely to get derailed, either. Kind of what I said, more of our board is going to multifamily and the Cemplank and the new construction more toward the bottom of the market so that's had some impact on price. Input costs have been good. Pulp's down. Freight. Freight is down slightly but we're managing freight better so we're actually doing pretty well there. Actually, this is one of the -- my disappointment is with the lower input costs, we're not taking advantage of them on the EBIT line as much as I thought we would. Now we do have higher fixed costs. We're doing a lot of the capacity work both in the U.S. and Australia, and that's showing up in our fixed cost, we call them MD&A. And of course, we've got the higher SG&A cost trying to get ready for more market share growth. In the Asia Pac, again, we're kind of figuring a flat to slightly better market in Australia next year. If it were better than that, we'd be ready for it and if it was worse than that, we'd have to react. But we're kind of seeing flat to slightly better is what we're planning around. The rest of that, they cover the $5.7 million. The rest of that was kind of in the slides. In the outlook, I don't think it's anything new. We're certainly not changing strategy. In the U.S., it's getting ready for market share growth, more market share growth, getting our capacity in line. And then in the Australian business especially, we do need to make a capacity decision which we haven't sorted out yet because we're trying to greenfield some capacity here and it's just coming in very expensive, so we haven't got it to a number that works yet. So we're still working on that. And Philippines and New Zealand, New Zealand is running better but the market's not great. It's not getting worse so we're running better in a flat or slightly better market. Okay, and like I said, the priorities are the same. We want to grow the business organically like we always try to do. We think we're into a window of opportunity in the market where that's going to be easier than in the past so we're willing to invest more money in it. We got to make sure we get our capacity reset because our product mix coming out of the downturn is different than into the downturn, so we're reengineering the Fontana plant for that. Before we start it up, we're looking at Summerville in the same way, plus we have 4 other capacity projects in the U.S. and then the one project down on here. So that's it. I'll hand it over to Russell, let him go through the financials and then let you guys drill down on your questions.